Article Information
History
- January 17, 2022.
Article Versions
- Version 1 (December 22, 2021 - 08:55).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
REVISION SUMMARY
Evaluation of Ag-RDTs with clinical samples added
Author Information
- Meriem Bekliz1,
- Francisco Perez-Rodriguez2,
- Olha Puhach1,
- Kenneth Adea1,
- Stéfane Marques Melancia2,
- Stephanie Baggio3,4,
- Anna-Rita Corvaglia1,
- Frédérique Jacquerioz-Bausch5,6,7,
- Catia Alvarez1,
- Manel Essaidi-Laziosi1,
- Camille Escadafal8,
- Laurent Kaiser2,5,9 and
- Isabella Eckerle1,5,9,*
- 1Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland
- 2Laboratory of Virology, Division of Infectious Diseases and Division of Laboratory Medicine, University Hospitals of Geneva & Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland
- 3Division of Prison Health, Geneva University Hospitals & University of Geneva, 1205 Geneva, Switzerland
- 4Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland
- 5Geneva Centre for Emerging Viral Diseases, University Hospitals Geneva, and University of Geneva, Switzerland
- 6Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland
- 7Primary Care Division, Geneva University Hospitals, Geneva, Switzerland
- 8FIND, Geneva, Switzerland
- 9Division of Infectious Diseases, Geneva University Hospitals, 1205 Geneva, Switzerland
- ↵*Corresponding author: Email: Isabella.Eckerle{at}hcuge.ch
Posted January 17, 2022.
Sensitivity of SARS-CoV-2 antigen-detecting rapid tests for Omicron variant
Subject Area
Reviews and Context
4
Comment
0
TRIP Peer Reviews
3
Community Reviews
0
Automated Services
75
Blogs/Media
Author Videos